Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Bending the rules.

[No authors listed]

Prescrire Int. 2011 Dec;20(122):288. No abstract available.

PMID:
22216540
2.

Botulinum toxin type A for migraine. First, do no harm.

[No authors listed]

Prescrire Int. 2011 Dec;20(122):287-90.

PMID:
22216539
3.

Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine.

Russell MB.

J Headache Pain. 2011 Apr;12(2):135-6. doi: 10.1007/s10194-011-0333-5. Epub 2011 Mar 27. No abstract available.

4.

Botox-A for suppression of chronic migraine: commonly asked questions.

Rothrock JF.

Headache. 2012 Apr;52(4):716-7. doi: 10.1111/j.1526-4610.2012.02121.x. No abstract available.

PMID:
22486743
5.

Botulinum toxin for chronic migraine.

[No authors listed]

Med Lett Drugs Ther. 2011 Jan 24;53(1356):7-8. No abstract available.

PMID:
21252842
6.

OnabotulinumtoxinA for the treatment of chronic migraine not quite there. . .

Torgovnick J.

Cephalalgia. 2011 Feb;31(3):377; author reply 378-9. doi: 10.1177/0333102410388529. Epub 2010 Nov 22. No abstract available.

PMID:
21098110
7.

[Prophylactic treatment with botulinum toxin type A].

Suzuki K, Iizuka T, Sakai F.

Nihon Rinsho. 2005 Oct;63(10):1815-20. Review. Japanese.

PMID:
16218396
8.

Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura.

Chankrachang S, Arayawichanont A, Poungvarin N, Nidhinandana S, Boonkongchuen P, Towanabut S, Sithinamsuwan P, Kongsaengdao S.

Headache. 2011 Jan;51(1):52-63. doi: 10.1111/j.1526-4610.2010.01807.x. Epub 2010 Nov 16.

PMID:
21083558
9.

Chronic Migraine with Medication Overuse and OnabotulinumtoxinA: Two Positive Case Reports of a Modified Injection Protocol.

Mazzucchi S, Cafalli M, Baldacci F, Lucchesi C, Bonuccelli U, Gori S.

Headache. 2016 Feb;56(2):402-3. doi: 10.1111/head.12773. No abstract available.

PMID:
26898483
10.

[Botox --against chronic migraine].

Sabourin G.

Perspect Infirm. 2012 Mar-Apr;9(2):54-5. French. No abstract available.

PMID:
22448444
11.

Botox for chronic migraine.

[No authors listed]

Drug Ther Bull. 2011 Feb;49(2):22-4; quiz iii-iv. doi: 10.1136/dtb.2010.10.0008. Review.

PMID:
21304165
12.

Evidence-based medicine: botulinum toxin A in migraine and tension-type headache.

Göbel H, Heinze A, Heinze-Kuhn K, Jost WH.

J Neurol. 2001 Apr;248 Suppl 1:34-8. Review.

PMID:
11357239
13.

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.

Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF; PREEMPT 2 Chronic Migraine Study Group.

Cephalalgia. 2010 Jul;30(7):804-14. doi: 10.1177/0333102410364677. Epub 2010 Mar 17.

PMID:
20647171
14.

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT 1 Chronic Migraine Study Group.

Cephalalgia. 2010 Jul;30(7):793-803. doi: 10.1177/0333102410364676. Epub 2010 Mar 17.

PMID:
20647170
15.

Let's give Botox a break.

Rothrock JF.

Headache. 2012 Jul-Aug;52(7):1204-5. doi: 10.1111/j.1526-4610.2012.02193.x. Epub 2012 Jun 13. No abstract available.

PMID:
22694357
16.

Botulinum toxin type A and acute drug costs in migraine with triptan overuse.

Christie SN, Giammarco R, Gawel M, Mackie G, Gladstone J, Becker WJ.

Can J Neurol Sci. 2010 Sep;37(5):588-94.

PMID:
21059503
17.
18.

Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults.

Silberstein S, Tfelt-Hansen P, Dodick DW, Limmroth V, Lipton RB, Pascual J, Wang SJ; Task Force of the International Headache Society Clinical Trials Subcommittee.

Cephalalgia. 2008 May;28(5):484-95. doi: 10.1111/j.1468-2982.2008.01555.x. Epub 2008 Feb 20. Erratum in: Cephalalgia. 2008 Jun;28(6):679.

PMID:
18294250
19.

Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database.

Rodgers AJ, Hustad CM, Cady RK, Martin VT, Winner P, Ramsey KE, Ho TW.

Headache. 2011 Mar;51(3):356-68. doi: 10.1111/j.1526-4610.2010.01771.x. Epub 2010 Oct 12.

PMID:
21039453
20.

Botulinum toxin in migraine.

Mishra A, Ghosh B, Das SK.

J Assoc Physicians India. 2003 Sep;51:896-9. Review. No abstract available.

PMID:
14710978

Supplemental Content

Support Center